Table 1 Epidemiological features of global human monkeypox patients recorded during 1970 − 24 July 2022
Features | All | Central Africa | Western Africa | Other Regions in Africaa | Europe | America | Other areas |
|---|---|---|---|---|---|---|---|
Total | 49,432 | 31,815 | 1246 | 34 | 11,992 | 4162 | 183 |
Type | |||||||
 Confirmed | 18,433 (37.29%) | 1823 (5.73%) | 363 (29.13%) | 7 (20.59%) | 11,989 (99.97%) | 4072 (97.84%) | 179 (97.81%) |
 Suspect or probable | 30,999 (62.71%) | 29,992 (94.27%) | 883 (70.87%) | 27 (79.41%) | 3 (0.03%) | 90 (2.16%) | 4 (2.19%) |
Genderb | |||||||
 Male | 2838 (86.55%) | 998 (80.29%) | 254 (68.83%) | 12 (50.00%) | 1038 (99.05%) | 505 (89.7%) | 31 (96.88%) |
 Female | 441 (13.45%) | 245 (19.71%) | 115 (31.17%) | 12 (50.00%) | 10 (0.95%) | 58 (10.3%) | 1 (3.13%) |
Ageb | |||||||
 0–14 | 3127 (64.82%) | 3068 (76.32%) | 34 (9.97%) | 15 (60.00%) | 2 (1.10%) | 7 (3.02%) | 1 (4.00%) |
 15–29 | 953 (19.76%) | 671 (16.69%) | 252 (73.90%) | 7 (28.00%) | 7 (3.87%) | 15 (6.47%) | 1 (4.00%) |
 30–59 | 736 (15.26%) | 276 (6.87%) | 55 (16.13%) | 3 (12.00%) | 169 (93.37%) | 210 (90.52%) | 23 (92.00%) |
  ≥ 60 | 8 (0.17%) | 5 (0.12%) | 0 (0.00%) | 0 (0.00%) | 3 (1.66%) | 0 (0.00%) | 0 (0.00%) |
Testing Methodbc | |||||||
 PCR | 348 (92.31%) | 218 (91.6%) | 5 (50.00%) | 3 (100%) | 92 (95.83%) | 26 (100.00%) | 4 (100.00%) |
 Next generation sequencing | 20 (5.31%) | 18 (7.56%) | 0 (0.00%) | 0 (0.00%) | 2 (2.08%) | 0 (0.00%) | 0 (0.00%) |
 Virus isolation | 7 (1.86%) | 2 (0.84%) | 5 (50.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 Electron microscope | 2 (0.53%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 2 (2.08%) | 0 (0.00%) | 0 (0.00%) |
Inpatientb | |||||||
 Yes | 225 (54.88%) | 57 (95.00%) | 41 (100%) | 8 (42.11%) | 70 (45.16%) | 34 (29.06%) | 15 (83.33%) |
 No | 185 (45.12%) | 3 (5.00%) | 0 (0.00%) | 11 (57.89%) | 85 (54.84%) | 83 (70.94%) | 3 (16.67%) |
Transmission modelb | |||||||
 Zoonotic infection | 608 (40.56%) | 594 (70.30%) | 14 (31.11%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 Community transmission | 320 (21.35%) | 153 (18.11%) | 19 (42.22%) | 6 (27.27%) | 135 (36.29%) | 7 (3.61%) | 0 (0.00%) |
 Travel-related infection | 194 (12.94%) | 0 (0.00%) | 3 (6.67%) | 4 (18.18%) | 81 (21.77%) | 85 (43.81%) | 21 (100.00%) |
 Probable MSM-related infection | 163 (10.87%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 148 (39.78%) | 15 (7.73%) | 0 (0.00%) |
 Household transmission | 113 (7.54%) | 93 (11.01%) | 8 (17.78%) | 8 (36.36%) | 4 (1.08%) | 0 (0.00%) | 0 (0.00%) |
 Infections via animal trade | 91 (6.07%) | 0 (0.00%) | 0 (0.00%) | 3 (13.64%) | 1 (0.27%) | 87 (44.85%) | 0 (0.00%) |
 Nosocomial infection | 10 (0.67%) | 5 (0.59%) | 1 (2.22%) | 1 (4.55%) | 3 (0.81%) | 0 (0.00%) | 0 (0.00%) |
Smallpox vaccinationb | |||||||
 No | 444 (75.64%) | 424 (75.44%) | 7 (87.50%) | 4 (100%) | 6 (85.71%) | 3 (50.00%) | 0 (0.00%) |
 Yes | 143 (24.36%) | 138 (24.56%) | 1 (12.50%) | 0 (0%) | 1 (14.29%) | 3 (50.00%) | 0 (0.00%) |
Animal contact historyb | |||||||
 Rodent | 175 (45.10%) | 84 (29.47%) | 3 (25.00%) | 0 (0.00%) | 0 (0.00%) | 87 (100.00%) | 1 (100.00%) |
 Monkey | 103 (26.55%) | 101 (35.44%) | 2 (16.67%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 Chimpanzee | 99 (25.52%) | 99 (34.74%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 Other animals | 11 (2.84%) | 1 (0.35%) | 7 (58.33%) | 3 (100.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
Outcomeb | |||||||
 Recover | 10,183 (97.23%) | 8894 (96.96%) | 1215 (99.10%) | 19 (100.00%) | 13 (100%) | 39 (100.00%) | 3 (100.00%) |
 Death | 288 (2.77%) | 279 (3.04%) | 11 (0.90%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
Number of cases | |||||||
 1970–1979 | 53 (0.11%) | 44 (0.14%) | 9 (0.72%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 1980–1989 | 116 (0.23%) | 115 (0.36%) | 1 (0.08%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 1990–1999 | 549 (1.11%) | 549 (1.73%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
 2000–2009 | 10,150 (20.53%) | 10,044 (31.57%) | 0 (0.00%) | 19 (55.88%) | 0 (0.00%) | 87 (2.09%) | 0 (0.00%) |
 2010–2019 | 17,063 (34.52%) | 16,445 (51.69%) | 612 (49.12%) | 0 (0.00%) | 4 (0.03%) | 0 (0.00%) | 2 (1.09%) |
 2020- July 2022 | 21,501 (43.50%) | 4618 (14.52%) | 624 (50.08%) | 15 (44.12%) | 11,988 (99.97%) | 4075 (97.91%) | 181 (98.91%) |